• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APIFIX LTD MID-C 125; POSTERIOR RATCHETING ROD SYSTEM,,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APIFIX LTD MID-C 125; POSTERIOR RATCHETING ROD SYSTEM,, Back to Search Results
Model Number MID-C 125
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Implant Pain (4561)
Event Date 02/22/2021
Event Type  Injury  
Manufacturer Narrative
Investigation: production process: a review of the dhr demonstrated that the mid-c system was manufactured, tested, and released according to apifix specifications.Patient removal surgery: the implant was removed due to pain.Culture swabs returned positive for infection by proprioni.Corrective action: the company decided to open (b)(4) to address late infection issue as part of the capa the company: performed a vast literature search to identify the late infection rate reported in the literature ((b)(4)).Investigated production lots associated with late infection.The compared antibiotic protocol used between centers.Received consultation by an infection specialist.The capa investigation did not identify a manufacturing problem with implants used in patients that developed a late infection and the late infection rate noted was within the rate reported in the literature.The company did however identify that sites applying vancomycin powder before wound closure have a significantly lower rate of late infection complaints.The use of vancomycin powder was also supported by the infection specialist consultation ((b)(4)).The company communicated these findings of applying vancomycin powder before wound closure to the surgeons ((b)(4)) and is continuing to follow the rate of late infection complaints.The present case was before the company's capa and regardless the surgeon does not use vancomycin antibiotics in any of the implantations.Risk assessment: the risk of pain is a known risk that has been assessed and found to be acceptable (dms#: (b)(4) rev q1).Event of pain addressed in the ifu warnings and precautions section: "metallic implants can loosen, fracture, corrode, migrate, or cause pain".Late-onset infection is a known risk that was assessed and recorded by the product risk assessment (b)(4) rev q hazard id 21.5 this complaint does not change the occurrences rate.The rates of late infection in surgeries where vancomycin was not used is 4.07% and 0.6% when used.The rate is well within the literature (0.2%-12.5% ,cer 727 rev t).The company is continuing to monitor late-infection complaints.
 
Event Description
On (b)(6) 2021, the distributor reported that the surgeon is a plan to perform a removal surgery on (b)(6) 2021.The patient complaint of pain.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MID-C 125
Type of Device
POSTERIOR RATCHETING ROD SYSTEM,,
Manufacturer (Section D)
APIFIX LTD
1 hacarmel street
kochav yokneam bldg
yokneam elit, 20692 07
IS  2069207
Manufacturer (Section G)
APIFIX LTD
1 hacarmel street
kochav yokneam bldg
yokneam elit, 20692 07
IS   2069207
Manufacturer Contact
adi prager
1 hacarmel street
kochav yokneam bldg
yokneam elit, 20692-07
IS   2069207
MDR Report Key11502792
MDR Text Key240589564
Report Number3013461531-2021-00011
Device Sequence Number1
Product Code QGP
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
H170001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,user faci
Reporter Occupation Other
Type of Report Initial
Report Date 03/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date11/25/2020
Device Model NumberMID-C 125
Device Catalogue NumberAF125
Device Lot NumberAF 11-01-15
Initial Date Manufacturer Received 02/21/2021
Initial Date FDA Received03/17/2021
Date Device Manufactured11/25/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-